A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes
Clinical trial NCT05254002 · COMPLETED
Trial details
- NCT number
- NCT05254002
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2025-03-14
- Enrollment
- 1664
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.